Project Grant 2027590

The National Science Foundation awarded a $255,957 STTR Phase I Project Grant to CHS Healthcare Ventures Inc., doing business as Lightengale, to develop a lighted infusion line to optimize care and decrease complications for critically ill patients in infectious isolation situations such as COVID-19. The grant is funded through the NSF's Technology, Innovation, and Partnerships program (CFDA 47.084) and aims to advance science and engineering research leading to breakthrough technologies and...

This $1 million cooperative agreement from the National Science Foundation's Technology, Innovation, and Partnerships program aims to develop a microbial discovery and biosynthesis platform for targeted protease inhibitors to treat COVID-19. Think Bioscience, Inc. will expand its demonstrated approach using microbial systems to guide the discovery and assembly of protease inhibitors. The company will generate new intellectual property covering the discovery platform and promising small molecules...

This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development of a label-free, high-resolution, high-throughput protein screening platform called Vibrational Spectroscopy with Metasurface Optics (VISMO). The technology aims to enable simultaneous, minute-scale measurement of millions of protein samples, which would dramatically improve the lengthy and costly cycles...

Altigg Therapeutics, Inc. was awarded a $255,595 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation's Engineering program (CFDA 47.041) for the period of April 1, 2021 through March 31, 2022. Under this award, Altigg Therapeutics will develop a platform for the rapid discovery of human antibodies as therapeutics for infectious diseases such as COVID-19. The NSF Engineering program seeks to improve quality of life and economic strength through...

Federal Project Grant Award Summary Spectral Therapeutics, Inc. received a $304,950 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) on July 1, 2026, with completion anticipated by March 31, 2027. The company is developing a novel, ultra-miniaturized drug discovery platform that integrates III-V semiconductor laser particles as spectral barcodes into polymer beads for...

The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...

This $1,000,000 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports research and development efforts by Akanocure Pharmaceuticals Inc. to optimize a novel, broad-spectrum antiviral and immunomodulatory agent for oral administration against coronaviruses. The project focuses on lead optimization, including the design, synthesis, and testing of analogs with improved drug-like properties for...

The National Science Foundation (NSF) awarded a $575,000 project grant under its Mathematical and Physical Sciences (MPS) program to the University of Wisconsin-Madison to study the use of light in organic synthesis. Under this 3-year award effective July 1, 2024, Professor Tehshik Yoon and his team will design novel photocatalysts that can interact directly with small molecules to control how they react and form more complex products. The research aims to transform discovery in pharmaceutical...

The National Science Foundation (NSF) awarded a $650,000 project grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to the University of Nevada, Reno to establish a point-of-care (POC) platform technology using smartphone-based time-resolved luminescence imaging and detection (STRIDE) enabled by manganese-doped semiconductor nanocrystals and artificial intelligence. This 1-year project will: (1) further develop the photophysics and optical properties of the...

This STTR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to transition the Ti:Sapphire-on-Insulator (Ti:SaOI) platform from an academic demonstration to a wafer-scale, CMOS-foundry compatible process. The $275,000 award, with a performance period from February 15, 2025 to October 31, 2025, will enable the scalable production of integrated Ti:Sapphire lasers and amplifiers in the wavelength range...